Item 2.02 - Results of Operations and Financial Condition

On January 11, 2021, Amicus Therapeutics, Inc. (the "Company") issued a press release announcing preliminary 2020 revenue and its 2021 strategic outlook, along with various business updates. A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

The information furnished pursuant to this Item 2.02, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.




Item 8.01 - Other Events

On January 11, 2021, the Company also published presentation materials which senior management will be using in its meetings with investors and analysts at the 39thAnnual J.P. Morgan Healthcare Conference. A copy of these materials is filed as Exhibit 99.2 to this Current Report on Form 8-K and is incorporated herein by reference

Item 9.01 Financial Statements and Exhibits





(d) Exhibits:



   Exhibit No.                             Description
      99.1          Press Release dated January 11, 2021
                    Presentation Materials - 39th Annual J.P. Morgan Healthcare
      99.2        Conference
                  Cover Page Interactive Data File (embedded within the Inline
       104        XBRL document)

© Edgar Online, source Glimpses